Fresenius Medical Care announces change to its EMEA region leadership.
M2 PHARMA-May 3, 2018-Fresenius Medical Care announces change to its EMEA region leadership
(C)2018 M2 COMMUNICATIONS
Fresenius Medical Care, a Germany-based provider of dialysis products and services, yesterday announced a leadership change in its EMEA (Europe, Middle East and Africa) region.
Effective 1 September 2018, Katarzyna Mazur-Hofsass, PhD, will assume the Management Board position in charge of EMEA. She succeeds Dominik Wehner in the position, who decided to step down for personal reasons, effective 31 December 2017. In the interim period, Rice Powell, chief executive officer of Fresenius Medical Care and chairman of the Management Board, manages the EMEA region.
Mazur-Hofsass has been president for EMEA at the med-tech company, Zimmer Biomet, since 2013. In her 25 years of professional career she has gained experience in the medical and pharma industry from her positions at Abbott Laboratories and Roche. She is a physician with a PhD from Gdansk Medical University in Poland, as well as an MBA from the Warsaw School of Economics and the University of Minnesota.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Date:||May 3, 2018|
|Previous Article:||Endo International announces participation at UBS Global Healthcare Conference.|
|Next Article:||AbbVie to Present at the 2018 Bank of America Merrill Lynch Health Care Conference.|